highperformr logo

NeoGenomics Laboratories's Overview

Total employees1626
HeadquartersFort Myers
Founded2002

NeoGenomics Laboratories is a premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and researchers globally. They specialize in providing comprehensive genetic and molecular testing critical for cancer diagnosis, prognosis, treatment selection, and clinical trial support. Their mission is to improve patient care and advance cancer research by delivering high-quality, innovative testing solutions and data insights.

Where is NeoGenomics Laboratories's Headquarters?

HQ Function

Serves as the global corporate headquarters, housing executive leadership, administrative functions, advanced diagnostic laboratories, and research and development facilities. It's a central site for strategic decision-making and innovation.

Notable Features:

The facility is a state-of-the-art, 150,000 square foot complex consolidating laboratory and corporate operations, designed to foster collaboration and efficiency. It includes advanced lab spaces for molecular, cytogenetic, and immuno-oncology testing.

Work Culture:

The work culture at NeoGenomics HQ emphasizes innovation, scientific excellence, collaboration, and a strong patient-first mentality. Employees are often driven by the mission to fight cancer and improve patient outcomes, contributing to a purposeful environment.

HQ Significance:

The Fort Myers headquarters is significant as it represents NeoGenomics' commitment to growth, technological advancement, and providing comprehensive cancer diagnostic services. It centralizes key operations, enhancing their ability to serve clients and partners effectively.

Values Reflected in HQ: The modern, integrated facility reflects NeoGenomics' values of innovation, quality, collaboration, and commitment to advancing cancer care through cutting-edge technology and expertise.

Location:

NeoGenomics Laboratories supports cancer diagnostics and pharmaceutical research globally. Key functions supported internationally include clinical diagnostic testing in multiple US locations, and specialized pharma services (including biomarker development, clinical trial testing, and data analysis) through laboratories and offices in the US, Europe (UK, Switzerland), and Asia-Pacific (Singapore, China operations through partnerships/subsidiaries). This global footprint enables them to serve a diverse client base of oncologists, hospitals, and biopharmaceutical companies worldwide, supporting both patient care and the development of new cancer therapies.

Street Address:

9490 NeoGenomics Way

City:

Fort Myers

State/Province:

Florida

Country:

USA

NeoGenomics Laboratories's Global Presence

Aliso Viejo, California, USA

Address: 31 Columbia, Aliso Viejo, CA 92656

Provides comprehensive diagnostic testing services to oncologists and pathologists in the region, supporting patient care with timely and accurate results.

Houston, Texas, USA

Address: 7256 S. Sam Houston Pkwy W, Suite 300, Houston, TX 77085

Supports oncological diagnostics for patients and clinicians in the Southern and Central United States, contributing to faster turnaround times for critical test results.

Cambridge, United Kingdom

Address: The Maurice Wilkes Building, St John's Innovation Park, Cowley Rd, Cambridge CB4 0DS, UK

Serves the European biopharma industry by providing specialized laboratory services for oncology drug development and clinical trials.

Rolle, Switzerland

Address: A-One Business Center, Route de l'Etraz, Z.A. La Pièce 1, Batiment A1, 1180 Rolle, Switzerland

Strategic hub for expanding Pharma Services and coordinating clinical trial support across the EMEA region.

Singapore

Address: 18 Gul Crescent, Singapore 629527

Facilitates oncology research and drug development for pharma partners operating in the APAC market, providing localized lab support.

Buying Intent Signals for NeoGenomics Laboratories

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of NeoGenomics Laboratories

As of April 2025, NeoGenomics Laboratories' leadership includes:

Chris Smith - Chief Executive Officer
William Bonello - Chief Financial Officer
Melody Harris - Chief People and Operations Officer
Warren Stone, M.D. - President, Clinical Services Division
Vishal Sikri - President, Advanced Diagnostics Division
Ali Tafreshi, Ph.D. - Chief Scientific Officer

Investors of NeoGenomics Laboratories

NeoGenomics Laboratories has been backed by several prominent investors over the years, including:

The Vanguard Group, Inc.
BlackRock Fund Advisors
State Street Global Advisors (SSgA Funds Management, Inc.)
Invesco Capital Management LLC
Primecap Management Company
Wasatch Advisors LP
Norges Bank Investment Management

Executive New Hires/Exits in the Last 12 Months

Hire4
Exits1

NeoGenomics has actively strengthened its executive leadership over the past 12-15 months with several key appointments in finance, operations, diagnostics, and scientific leadership, alongside a planned retirement. These changes aim to drive growth and innovation in both clinical and pharma services.

Departures

Kathryn McKenzie, Kathryn McKenzie retired as Chief Financial Officer.

New Appointments:

William 'Bill' Bonello, William 'Bill' Bonello appointed as new Chief Financial Officer.
Vishal Sikri, Vishal Sikri appointed as President, Advanced Diagnostics Division.
Melody Harris, Melody Harris appointed as new Chief People and Operations Officer.
Ali Tafreshi, Ph.D., Dr. Ali Tafreshi appointed as new Chief Scientific Officer.
Warren Stone, M.D., Dr. Warren Stone promoted to President, Clinical Services Division.

Technology (Tech Stack) used by NeoGenomics Laboratories

Discover the tools NeoGenomics Laboratories uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

NeoGenomics Laboratories Email Formats and Examples

NeoGenomics Laboratories likely utilizes common corporate email formats. Based on industry patterns, the most probable format is combining the first initial with the last name, or first name and last name separated by a dot.

A common format is [first_initial][last]@neogenomics.com or [first].[last]@neogenomics.com

Format

jsmith@neogenomics.com

Example

75%

Success rate

News and media

NeoGenomics IRFebruary 27, 2024

NeoGenomics Laboratories Reports Fourth Quarter and Full Year 2023 Financial Results

NeoGenomics announced its financial performance for Q4 and full year 2023, highlighting revenue growth and progress in its strategic initiatives, including advanced diagnostics and pharma services....more

NeoGenomics IRJanuary 8, 2024

NeoGenomics Laboratories Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NeoGenomics announced inducement grants to new employees, including Melody Harris, its new Chief People and Operations Officer, as part of their employment commencement....more

NeoGenomics IRNovember 29, 2023

NeoGenomics Laboratories Strengthens Executive Leadership Team with Key Appointments

NeoGenomics announced the appointments of Melody Harris as Chief People and Operations Officer and Ali Tafreshi, Ph.D., as Chief Scientific Officer, and the promotion of Warren Stone, M.D., to President, Clinical Services Division....more

BioPharma ReporterOctober 10, 2023

NeoGenomics Laboratories Opens New Advanced Laboratory in Singapore

NeoGenomics announced the opening of a new, state-of-the-art pharma services laboratory in Singapore to enhance its support for biopharmaceutical clients in the Asia-Pacific (APAC) region....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including NeoGenomics Laboratories, are just a search away.